Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over […]
Business
Pharming Group reports third quarter 2024 financial results and provides business update
Pharming Group N.V. Third quarter 2024 total revenues increased by 12% to US$74.8 million, compared to the third quarter 2023,
argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
argenx SE October 24, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to
Good Natured Products Inc. Provides Update on Restructuring of Business Operations and Financial Affairs
Vancouver, British Columbia–(Newsfile Corp. – October 24, 2024) – good natured Products Inc. (TSXV: GDNP.H) (OTC Pink: GDNPF) (the “Company”
